Zhixu He
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents 3
- Cancer Research top 10%
- Molecular Biology top 10%
- RNA modifications and cancer 4
- RNA Interference and Gene Delivery 3
- Epigenetics and DNA Methylation 3
- Genomics, phytochemicals, and oxidative stress 2
- Oncology top 10%
- Cancer-related Molecular Pathways 5
-
- Microtubule and mitosis dynamics 3
-
- Echinoderm biology and ecology 3
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Zhixu He
51 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 122
- Toxicology 81
- Cancer Research 254
- Molecular Biology 833
- Oncology 305
- Complementary and alternative medicine 62
Countries citing papers authored by Zhixu He
This map shows the geographic impact of Zhixu He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhixu He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhixu He more than expected).
Fields of papers citing papers by Zhixu He
This network shows the impact of papers produced by Zhixu He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhixu He. The network helps show where Zhixu He may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhixu He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 8 | |
| 5 | 2022 | 3 | |
| 6 | 2020 | 29 | |
| 7 | 2019 | 12 | |
| 8 | 2018 | 1 | |
| 9 | 2018 | 13 | |
| 10 | 2018 | 38 | |
| 11 | 2018 | 16 | |
| 12 | 2018 | 54 | |
| 13 | 2018 | 33 | |
| 14 | [Effect of Doxorubicin on abcb4 Gene Expression in Zebrafish (Danio rerio) Embryos]. | 2016 | 1 |
| 15 | 2016 | 1 | |
| 16 | 2016 | 321 | |
| 17 | 2015 | 25 | |
| 18 | 2015 | 30 | |
| 19 | 2015 | 36 | |
| 20 | 1997 | 1 |
About Zhixu He
Zhixu He is a scholar working on Toxicology, Aging and Applied Microbiology and Biotechnology, having authored 52 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), RNA modifications and cancer (4 papers), RNA Interference and Gene Delivery (3 papers), Microtubule and mitosis dynamics (3 papers), Bioactive Compounds and Antitumor Agents (3 papers), Epigenetics and DNA Methylation (3 papers), Echinoderm biology and ecology (3 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). The work is most often cited by research in Toxicology (81 citations), Cancer Research (254 citations) and Molecular Biology (833 citations). Zhixu He has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Shu‐Feng Zhou, Jiaxuan Qiu, Shuting Pan, Zhiling Li, Xueji Zhang, Yinxue Yang, Chuan Ye, Tianxin Yang, Xiao‐Wu Chen and Chuanhai Cao. Their work appears in journals such as Blood, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.